Skip to content

Pink Zone Pattern (PP) sign combined with VS system in the diagnosis of early gastric cancer: a prospective study

Pink Zone Pattern (PP) sign combined with VS system in the diagnosis of early gastric cancer: a prospective study

Status
Active, not recruiting
Phases
Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400080104
Enrollment
Unknown
Registered
2024-01-19
Start date
2022-10-01
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer

Interventions

Index test:A total of 400 suspected patients with early gastric cancer were included to evaluate and compare the sensitivity, specificity, positive predictive value and negative predictive value of "V

Sponsors

Zhejiang Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) Age =18 years old, gender is not limited; (2) ECOG score 0 or 1; (3) The patient underwent routine white light endoscopy to exclude benign lesions such as gastric ulcers, and further ME-NBI examination was required considering the possibility of malignancy; (4) No previous tumor-related history; (5) Gastroscopy and pathological examination can be performed within 7 days after signing the informed consent; (6) Subject and family members are able to understand the study protocol and are willing to participate in the study, providing written informed consent.

Exclusion criteria

Exclusion criteria: (1) History of other tumor diseases, or other genetic diseases; (2) Patients with serious medical diseases, such as grade III or above cardiac dysfunction (NYHA criteria), ischemic heart disease, heart infarction, or angina pectoris, or heart infarction 6 months before screening, poorly controlled diabetes, poorly controlled hypertension, and echocardiographic ejection fraction 6mg/L; (5) The subject or family member is unable to understand the conditions and objectives of the study.

Design outcomes

Primary

MeasureTime frame
Histologic type of the lesion;Sensitivity;Specificity;Positive predicative value;

Secondary

MeasureTime frame
negative predictive value;

Countries

China

Contacts

Public ContactShi Wang

Zhejiang Cancer Hospital

wangshi@zjcc.org.cn+86 135 8840 3693

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026